MedPath

The effects of plant stanols on the immune function of asthma patients

Withdrawn
Conditions
allergy
Asthma
10001708
10038716
Registration Number
NL-OMON34639
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

Asthma
Age between 18 and 70
Men and women
Specific anti-hepatitis A virus antibody titers < 20 IU/L

Exclusion Criteria

- Current asthmatic exacerbations, i.e. use of prednisone or pneumoia
- Other immune-related pathology, e.g. autoimmune diseases, diabetes, HTLV, HIV, other inflammatory diseases than asthma.
- Previously being vaccinated against hepatitis A
- Pregnancy or lactation
- Impaired liver and kidney function
- Use of immunosuppressive medication
- Allergy to neomycin
- Throbocytopenia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Specific anti-HAV antibody titers after vaccination</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Phagocytic capacity of neutrophils; NK-cell activity; Th1 and Th2 cytokine<br /><br>production profiles by PHA stimulated PMBCs.</p><br>
© Copyright 2025. All Rights Reserved by MedPath